tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Technical Analysis

1,145 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Grace Therapeutics’s (GRCE) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Grace Therapeutics is a Buy.
Grace Therapeutics’s (GRCE) 20-Day exponential moving average is 3.75, while Grace Therapeutics’s (GRCE) share price is $3.82, making it a Buy.
Grace Therapeutics’s (GRCE) 50-Day exponential moving average is 3.48, while Grace Therapeutics’s (GRCE) share price is $3.82, making it a Buy.

Grace Therapeutics (GRCE) Pivot Points

Dec 22, 2024, 01:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.22
3.43
3.75
3.96
4.28
4.49
4.81
Fibonacci
3.43
3.64
3.76
3.96
4.17
4.29
4.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Grace Therapeutics (GRCE) Moving Averages

Dec 22, 2024, 01:24 PM
Period
Simple
Exponential
MA5
3.84Sell
3.87Sell
MA10
3.90Sell
3.86Sell
MA20
3.77Buy
3.75Buy
MA50
3.44Buy
3.48Buy
MA100
3.04Buy
3.25Buy
MA200
3.04Buy
3.12Buy
Grace Therapeutics’s (GRCE) 10-Day exponential moving average is 3.86, while Grace Therapeutics’s (GRCE) share price is $3.82, making it a Sell.
Grace Therapeutics’s (GRCE) 100-Day exponential moving average is 3.25, while Grace Therapeutics’s (GRCE) share price is $3.82, making it a Buy.
Grace Therapeutics’s (GRCE) stock price is $3.82 and Grace Therapeutics’s (GRCE) 50-day simple moving average is 3.44, creating a Buy signal.
Grace Therapeutics’s (GRCE) stock price is $3.82 and Grace Therapeutics’s (GRCE) 100-day simple moving average is 3.04, creating a Buy signal.
Grace Therapeutics’s (GRCE) stock price is $3.82 and Grace Therapeutics’s (GRCE) 200-day simple moving average is 3.04, creating a Buy signal.

Grace Therapeutics (GRCE) Technical Indicators

Dec 22, 2024, 01:24 PM
Name
Value
Implied Action
RSI (14)
53.38
Neutral
STOCH (9,6)
37.14
Neutral
STOCHRSI (14)
38.46
Neutral
MACD (12,26)
0.15
Buy
ADX (14)
24.78
Neutral
Williams %R
-65.99
Buy
CCI (14)
30.53
Neutral
ATR (14)
0.37
-
Ultimate Oscillator
37.55
Neutral
ROC
15.76
Buy
Grace Therapeutics’s (GRCE) Relative Strength Index (RSI) is 53.38, creating a Neutral signal.
Grace Therapeutics’s (GRCE) Trend Strength Indicator (ADX) is 24.78, creating a Neutral signal.
Grace Therapeutics’s (GRCE) Commodity Channel Index (CCI) is 30.53, creating a Neutral signal.
Grace Therapeutics’s (GRCE) Price Rate of Change (ROC) is 15.76, creating a Buy signal.

FAQ

Is GRCE a Buy, Hold, or Sell?
Based on GRCE’s technical indicators, GRCE is a Buy.
    What is GRCE’s RSI (14)?
    GRCE’s RSI (14) is 53.38, which suggests GRCE is a Neutral.
      What is GRCE’s MACD?
      GRCE’s MACD is 0.15, which suggests GRCE is a Buy.
        What is GRCE’s 5-day moving average?
        GRCE’s 5-day moving average is 3.84, which suggests GRCE is a Sell.
          What is GRCE’s 20-day moving average?
          GRCE 20-day moving average is 3.77, which suggests GRCE is a Buy.
            What is GRCE’s 50-day moving average?
            GRCE’s 50-day moving average is 3.44, which suggests GRCE is a Buy.
              What is GRCE’s 200-day moving average?
              GRCE’s 200-day moving average is 3.04, which suggests GRCE is a Buy.
                What is GRCE’s Williams % R (14)?
                GRCE’s Williams % R (14) is -65.99, which suggests GRCE is a Buy.
                  What is GRCE’s CCI (14)?
                  GRCE’s CCI (14) is 30.53, which suggests GRCE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis